Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03983993
Title Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer (NIPAVect)
Acronym NIPAVect
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Emory University
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST